The results showed that in treatment of bone marrow (BM) specimen collected from AML patient for 4 days, Am80‐GCSF induced significantly higher ROS production than did GCSF or Am80 while sustaining proliferation similar to GCSF (Fig 2Ai and ii). The gene discussed is CSF3; the disease is acute myeloid leukemia.